Your point is, of course, that there are no recent financials reported. Correct. NNLX is a pink sheet start-up with no reporting obligation. It will report when revenue is profitable and sustained. That is what I glean from year-end summary. This investment is not for those who want the reporting system required for the NAZ or NYSE. We invested because of NNLX's revolutionary technology and state-of-the-art diagnosing products, patents issued here (some pending), in the EU, and other countries.
Parents